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Abstract
Background: Use of Shared Decision-Making (SDM) and Decision Aids (DAs) has been encouraged but is not
regularly implemented in primary care. The Office-Guidelines Applied to Practice (Office-GAP) intervention is an
application of a previous model revised to address guidelines based care for low-income populations with diabetes
and coronary heart disease (CHD). Objective: To evaluate Office-GAP Program feasibility and preliminary efficacy on
medication use, patient satisfaction with physician communication and confidence in decision in low-income
population with diabetes and coronary heart disease (CHD) in a Federally Qualified Healthcare Center (FQHC).
Method: Ninety-five patients participated in an Office-GAP program. A quasi-experimental design study, over
6 months with 12-month follow-up. Office-GAP program integrates health literacy, communication skills education
for patients and physicians, patient/physician decision support tools and SDM into routine care. Main Measures: 1)
Implementation rates of planned program elements 2) Patient satisfaction with communication and confidence in
decision, and 3) Medication prescription rates. We used the GEE method for hierarchical logistic models, controlling
for confounding.
Results: Feasibility of the Office-GAP program in the FQHC setting was established. We found significant increase in
use of Aspirin/Plavix, statin and beta-blocker during follow-up compared to baseline: Aspirin OR 1.5 (95 % CI: 1.1, 2.
2) at 3-months, 1.9 (1.3, 2.9) at 6-months, and 1.8 (1.2, 2.8) at 12-months. Statin OR 1.1 (1.0, 1.3) at 3-months and 1.5
(1.1, 2.2) at 12-months; beta-blocker 1.8 (1.1, 2.9) at 6-months and 12-months. Program elements were consistently
used (≥ 98 % clinic attendance at training and tool used). Patient satisfaction with communication and confidence
in decision increased.
Conclusions: The use of Office-GAP program to teach SDM and use of DAs in real time was demonstrated to be
feasible in FQHCs. It has the potential to improve satisfaction with physician communication and confidence in
decisions and to improve medication use. The Office-GAP program is a brief, efficient platform for delivering patient
and provider education in SDM and could serve as a model for implementing guideline based care for all chronic
diseases in outpatient clinical settings. Further evaluation is needed to establish feasibility outside clinical study,
reach, effectiveness and cost-effectiveness of this approach.
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Background
According to the Chronic Care Model, disease manage-
ment is best provided through collaboration between the
patient and the healthcare team [1]. The Patient Cen-
tered Medical Home and Meaningful Use criteria expect
patients to be actively involved in the decision making
and management of their chronic conditions [2–4]. Pa-
tients who become informed and active participants in
decision making consistently experience a positive im-
pact on their health outcomes [2–5]. As described by
Wagner et al. high quality medical care for chronic ill-
ness must accomplish three objectives, [6]: 1) assure the
delivery of those interventions that have been shown by
rigorous evidence to be effective, 2) empower patients to
take responsibility for the management of their condi-
tion, and 3) provide information, support, and resources
to assist patients in self -management tasks. The collab-
orative care model described by Wagner remains an
ideal but often elusive goal of care systems [6]. The use
of Shared Decision Making (SDM) and decision aids
(DAs) to accomplish the collaborative model has been
encouraged but not regularly implemented in primary
care. Shared decision-making has been defined as: “an
approach where clinicians and patients share the best
available evidence when faced with the task of making
decisions, and where patients are supported to con-
sider options, to achieve informed preferences” [7]. At
its core, SDM rests on accepting that individual self-
determination is a desirable goal and that clinicians
need to support patients to achieve this goal, wher-
ever feasible [8].
Physician and patient interventions designed in tan-
dem to support the therapeutic partnership from both
perspectives have been advocated but infrequently im-
plemented [9]. The challenge is how to support patients
and providers to develop new behaviors and knowledge
about treatment options and communication skills ne-
cessary for collaboration and shared decision making
(SDM). Only a few studies have simultaneously inter-
vened with both patients and providers and objectively
measure intervention effects on health outcomes [10].
Furthermore, some patient-activation interventions
designed to improve patient-physician communica-
tion have been tested in patients with chronic
diseases, but relatively few have used targeted strat-
egies, and focused on ethnic minorities and low
socio-economic populations who typically have lower
levels of engagement and poorer communication
with providers [11]. Cooper et al. [11] found that in-
terventions that enhance physicians’ communication
skills and activate patients to participate in their care
positively affect patient-centered communication,
patient perceptions of engagement in care and may
improve systolic blood pressure among urban African-
American and low socioeconomic status patients with
uncontrolled hypertension. The greatest improvements
were seen among patients who received coaching by a
community health worker and whose physicians also
received patient-centered communication skills train-
ing [11]. Stacey et al. [12] in their Cochrane review of
DAs for people facing health treatment or screening
decisions found high-quality evidence that DAs com-
pared to usual care improve people’s knowledge re-
garding options, and reduce their decisional conflict
related to feeling uninformed and unclear about their
personal values. In addition, their study revealed mod-
erately quality evidence that DAs compared to usual care
stimulate people to take a more active role in decision
making. They however concluded that the effects of DAs
on adherence with the chosen option, cost-effectiveness,
use with lower literacy populations, and level of detail
needed in DAs need further evaluation [12].
Our study addresses the need for more research on
use of SDM and DAs, the translation of evidence-based
decision support interventions and the implementation
of guidelines based care into practice especially in com-
munity outpatient settings that provide care for minority
low income populations [12–15].
We previously developed an integrated shared decision
making (SDM) intervention [16] based on our research
in communication skills training for both patients and
providers [17, 18], and provision of problem-specific de-
cision support tools [19, 20]. Our prior study focused on
decisions about exercise stress testing in stable coronary
artery disease and was underpowered to evaluate the im-
pact on patient behavior. In the present study, we used
our intervention approach to encourage SDM in guide-
lines-based medication use in coronary heart disease
(CHD) among patients with diabetes/CHD receiving
care in a Federally Qualified Health Center (FQHC).
FQHCs provide care for over 22 million people in
9000 communities in US [21]. They play a vital role
in caring for the poor and medically underserved,
underinsured, and uninsured Americans, including
migrant workers and non-US citizens. Most of these
patients are at higher risk of cardiovascular disease
and underuse of guidelines based care [22, 23]. We
tested the feasibility of the intervention process in
the new application and performed a preliminary test
of the impact of the intervention on patient satisfac-
tion with communication with their provider and
confidence in decision made and on medication use.
We used the approach from our previous work [16]
and provided specific decision support tools to create
a simple, parsimonious strategy as a new intervention
in primary care we call the Office Guidelines Applied
to Practice (Office-GAP) to improve prevention of cor-
onary heart disease (CHD) in outpatient settings.
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Our objectives were to evaluate: 1) feasibility of the
Office-GAP program among patients with diabetes
and CHD in a Federally Qualified Healthcare Center
(FQHC); 2) the impact on a) patient satisfaction with
physician communication and confidence in decisions;




A one-group, pretest-posttest quasi-experimental de-
sign was adopted over 6 months, followed by a 12-
month follow-up. The study site was the Ingham
County Healthcare Center in Mid-Michigan, a desig-
nated FQHC. Patients with diabetes and/or heart dis-
ease were recruited through direct provider referrals
and on-site recruitment using patient ICD Code. At
the visit to the primary practice where diabetes or
heart disease, or both is on the problem list, practice
staff informed patients about the study and directed in-
terested patients to the research assistant (RA) for
more information. The RA briefly described the pro-
ject to the patient; if patient was interested, he/she
was scheduled for a group visit; Consent and Health
Insurance Portability and Accountability Act (HIPAA)
forms were completed during the group visit. All pro-
viders, practice staff and patients signed informed
consent documents. The Michigan State University
(MSU) Institutional Review Board (IRB) approved the
study.
Inclusion criteria
Adults aged 18 or older, who could provide informed
consent and who sought care from September 2009 to
December 2011. ICD codes were used to identify pa-
tients with a diagnosis of 1) Diabetes mellitus. 2) Coron-
ary heart disease. 3) All doctors and nurse practitioners
providing care for patients at the study site.
Exclusion criteria
Adults with cognitive impairment, dementia and psych-
osis as determined by ICD codes. Patient race was self-
reported.
Interpreters were used to obtain information from pa-
tients who could not speak English. Study participants
received 30-dollar reimbursement for transportation and
parking fees.
All providers in the clinic and practice staff
(Nurses, Medical Assistants, Administrators, Recep-
tionists, and Social Workers) were recruited into the
study. An informational meeting was offered at 4
different times to accommodate staff schedules. Two
doctors (one internal medicine physician and 1 family
medicine physician), 1 nurse-practitioner (NP), 8 staff,
and 95 patients with a diagnosis of CAD or diabetes
mellitus in one FQCHC participated in this pilot
study.
Conceptual framework
The Office-GAP model (Fig. 1) is based on the Health
Literacy Care Model (HLCM) [24] and the Relational
Coordination model [25]. The HLCM is a systems
approach to improving patients’ engagement in care. Re-
lational coordination refers to the quality of communica-
tion that strengthens interpersonal relationships [25, 26].
This is fundamental to collaborative goal setting that
both patients and providers will embrace.
Program elements show how Office-GAP operationa-
lizes key constructs in the Relational Coordination
model that enhance relational coordination among pro-
viders and patients (Table 1). Relational coordination
originally referred to the quality of communication
among individuals in a work setting, and is understood
as a function of the quality of those professionals’ inter-
personal relationships [25]. We focused on strong
provider-patient relationships as described in the HLCM
[24]. The HLCM, weaves health literacy strategies into
the widely accepted Wagner Care Model [6]. The Care
Model represents an evidence-based framework that
promotes the delivery of safe, effective, and collaborative
care to patients. Measures of relational coordination
have been positively correlated with outcomes in health
systems [27] and integrated care in hospitals [28] and re-
lational coordination has been shown to improve results
in primary care and in community settings [29]. Havens
et al. [26] report on the specific features of high-quality
communication and provider relationships leading to
strong relational coordination. Table 1 below summa-
rizes the way the features of Office-GAP met the criteria
discussed by Havens [26].
SDM and the HLCM both aim to improve product-
ive interactions between informed, activated patients
and a prepared, proactive practice team. The purpose
is to go beyond informed decision making and pater-
nalistic models, in which communication is one way
between clinicians and patients, and to achieve two-
way communication and SDM [8]. Our model expli-
citly identifies two aspects of the model that are often
overlooked [30]. One is to directly identify the
choices patients are offered (the framing problem).
The framing problem in our model is answered by
limiting the decision space to choices supported by
guidelines. In CHD/diabetes, the clinical cases that
provide the preliminary test of the model, choices
offered are among known efficacious medical and be-
havioral treatments. The other aspect of the inter-
action is to deliberately address how the patient is
involved (the nature of reasoning problem). The
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communication represented in joint decision making
(the nature of reasoning) is answered by explicitly de-
scribing the pros and cons of identified treatments
and encouraging the patient and physician to openly
discuss each to reach a shared decision about a treat-
ment plan. The process continues with patient values
clarification and shared-decision-making to formulate a
treatment plan.
Study interventions
The Office-GAP tools were grounded in the Guidelines
of the American Heart Association/American College of
Cardiology (AHA/ACC) on secondary prevention of
heart disease [31] and those of the American Diabetes
Association (ADA) [32]. The process, developed previ-
ously [16], consisted of three Office-GAP components:
1) Physician and practice staff training; 2) Patient Group
Visit; and 3) Use of the Office-GAP checklist tool during
follow-up provider visits. The checklist tool [33] aided
SDM and communication between patient and provider.
Components were scripted and monitored to maintain
study fidelity [34].
Physician and practice staff communication skills
intervention
The physician communication intervention was a 90-
min training offered at 4 different times to accommo-
date staff schedules. Training included review of CHD
secondary prevention guidelines and communication
skills. Discussions on Steps in Patient-Centered Care
Method of Communication (PTC) [18], SDM and goal
setting, was led by Dr. Robert Smith, a world re-
nowned expert in teaching PTC. The communication
skills training goal was to increase patient engage-
ment, activation, goal setting and empowerment. The
intervention focused on strong provider-patient rela-
tionships as described in the HLCM and Relational
Coordination Model. The research team, providers
and practice staff discussed the best strategy for
implementing the Office-GAP tools in the practice
and their use during patient encounters with their
providers. We identified possible opportunities and
pitfalls of the study. Role-plays were conducted to
model office visit skills. The training section was eval-
uated by surveying participating physicians and prac-
tice staff at the end of the training.
Patient intervention
Patients attended one group visit to learn SDM, commu-
nication skills and review decision support tools parallel
Fig. 1 Office-GAP model
Table 1 Elements of relational coordination of shared decision
making implemented in Office-GAP
High quality
Communication is… Office GAP Program
element
Measured by

















Shared goals Checklist COMRADE39














Pros and cons of treatments
Confidence in care
plan
“We are on the
right track”
COMRADE39
aADA/ACP: American Diabetic Association/American College of Physician
bData available upon request
COMRADE combined outcome measure for risk communication and treatment
decision making
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to skills targeted in the physician intervention. Patient
pre-visit coaching has been shown to improve patients’
communication with their physicians and health out-
comes [35]. We define decision support tools to include
the Office-GAP checklist tool and two decision aids
to support patient decision making about CHD (“Liv-
ing with CHD” a 35 min DVD and Pamphlet [36]
and ADA/ACP Booklet (“Living with Diabetes” [37]).
How to use the GAP Agreement for Heart Health/
Checklist during office visit with their physician was
discussed. The Office-GAP checklist was written at
the 6th grade reading level. Two follow-up visits at 3
and 6 months were scheduled with patients’ primary
care physician using the Office-GAP checklist tool
described in more details below. The group visits
included four to six patients, were scheduled for a
90–120 min/group visit and were conducted by the
Research Assistant and PI (AO).
Group visit
Introduction to CHD and life style changes was pre-
sented through viewing the CHD decision aid [36] that
included scientific information and patient interviews
about secondary prevention and living with CHD.
Purpose and side effects of cardiac medications were
discussed by a physician (AO) with a Research Assist-
ant. The ADA/ACP Booklet “Living with Diabetes”
was reviewed to set goals. Principles of SDM and
how to interact with physicians during office visit
were discussed. The program focused on patient com-
munication skills related to engagement, SDM, activa-
tion and empowerment consistent to the provider
intervention skills [38, 39].
Clinic visit
The Office-GAP Checklist (The GAP-Agreement for
Heart Health Checklist) [33] was used to stimulate SDM
and aid communication and impact the process of care
by providing a systematic list of evidence based medica-
tions/ interventions for patient and provider to review
together. The use of the checklist during routine office
visit was an added reinforcement of the group visit
SDM and patient engagement process. The Office-
GAP Checklist served as the core SDM reminder
tool. It was completed in real time by the physician
and patient at two separate office visits (at 3 and
6 months). A SDM process was used to agree on
medication use and life-style changes. For each
guideline based item in the list, the physician
checked, Yes (if patient was on the medication or life
style activity), or No or Does Not Apply to me
because…. (if the patient was not eligible for the
medication, had a contraindication, or was unwilling
due to side effect concerns). Physician and patient
discussed each item before the physician checked the
box. The Office-GAP Checklist also stated the next
follow-up details. At the end of the visit the phys-
ician and patient signed the checklist form to con-
firm that both of them has reviewed and discussed
all the items. A copy of the checklist went to the




The intervention feasibility was assessed by 1) Physicians’
and Office staff attendance at the providers’ educational
meetings, 2) patient group visits and follow ups’ attend-
ance, and 3) Office-GAP tool utilization rate abstracted
from the medical record.
Efficacy
1) Patient satisfaction with communication and
confidence in decision
The COMRADE survey [40] assessed the patient’s
satisfaction with provider communication during
the encounter, the information they received and
confidence in the decisions made with their
provider regarding their care. The previously
validated COMRADE survey contains two
sub-scales: 1) satisfaction with physician
communication, and 2) patient confidence in
decision made [40]. The full survey consists
of 20 items that was administered at three times:
at initial group visit (pre-GAP, 0 months), and
at two subsequent post-GAP visits with their
physician (3, 6 months) [40] It states “we would
like to talk with you about your discussions with
your physician” and it includes questions such as
“The doctor made me aware of the different
treatments available,” “The doctor gave me a
chance to be involved in the decisions during the
consultation”. “I know the advantages of treatment
or not having treatment”. “My doctor and I agreed
about which treatment (or no treatment) was best
for me”. “I am satisfied with the way in which the
decision was made in the consultation”. “I can
easily discuss my condition again with my doctor”.
“I feel an informed choice has been made”.” Overall, I
am satisfied with the information I was given”.
At baseline patients were asked to assess their
satisfaction with their provider’s communication
and confidence in decision made with their
provider during their last office visit using the
COMRADE survey.
All items used a Likert response format
(1 = strongly disagreed to 5 = strongly agree).
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Research Assistants explained the questions and
helped only patients with limited literacy to
complete the forms at each visit. Rates of using
aspirin, beta-blocker, ACEI/ARBs, and cholesterol
treatment were obtained at baseline, 3, 6 and
12 months as primary endpoints.
2) Medication Use
Medication use was assessed by self-report at
each visit and confirmed by patients bringing in
all active medications, (validated by presence of
the prescription in the medical record). This
also verified that prescription was filled.
Statistical analysis
For descriptive statistics we used mean and standard de-
viation (SD) for continuous variables and frequency and
percentage for discrete variables. To test for the effect of
the Office-GAP intervention on perceived satisfaction
with communication and confidence in decision, we
summed raw scores on items 1 to 10 for satisfaction
subscale scores and items 11 to 20 for the confidence
subscale scores. The resulting scores for both subscales
could range from 10 to 50, with high scores indicating
more satisfaction and more confidence. We used the
generalized estimating equations (GEE) method [41] to
estimate hierarchical linear models to account for the
correlations of the subscale scores within the same patient,
controlling for patient’s age, race, gender, primary insur-
ance and Charlson index. These analyses tested whether
the mean subscale scores were higher at each of the post
Office-GAP assessment (at 3 and 6 months) than they had
been at the pre-Office GAP visit (0 month/baseline).
For medication use data, we used the GEE method [41]
for hierarchical logistic models, controlling for the same
covariates as above. Only medication eligible patients were
included in the analysis for specific adherence, resulting in
different numbers of patients in each model. Medication
eligibility criteria was based on guidelines and followed
previous studies [42–45] (Appendix 1). “Extending our
statistical analysis for medication use, we created a
“global” medication adherence measure based on the
following algorithm: a variable that equals to the ad-
herence for ACEI if the patient was eligible for ACEI,
else equals to the adherence for aspirin if the patient
was eligible for aspirin; else equals to the adherence
for statin if the patient was eligible for statin; and
else equals the adherence for beta-blocker if the pa-
tient was eligible for beta-blocker.
Worst-case scenario imputation was carried out for
3 patients with missing data at 12-month follow up.
Software
All analyses were performed using Stata 13 [46].
Results
One hundred and forty-six patients met the inclusion
criteria but only 95 (65 %) patients with CHD and/or
diabetes participated in the study (Table 2). Reasons for
non-participation included, refusal to participate, some
indicated willingness to participate but did not show up
for the group visit, some patients could not be contacted
for scheduling for group visit because their phone were
disconnected. On average the patients were 53.2 (SD
10.3) years of age, with BMI 36.9 (SD 10.2) and Charlson
Index 2.6 (SD 1.5) indicating substantial risk of mortality
within the next 10 years for a typical patient [47]. The
majority of patients were female (53.7 %), white (51.6 %),
with Medicare or Medicaid insurance (52.6 %), and
8.4 % were uninsured.
Intervention feasibility and program fidelity
Office-GAP was consistently implemented. All pro-
viders and staff attended the 90-min physician train-
ing. Among the 95 patients who attended the first
90-min group visits, 77 (81.1 %) completed their first
Office-GAP provider visit; 60 (63.2 %) completed
their second (final) visit. The Office-GAP tool was
found completed in the medical record 98.7 % of the
time. The clinic staff made sure that every patient
goes into the consulting room with the Office-GAP
checklist. We checked that both the provider and pa-
tient signed the Office-GAP checklist at the end of
each encounter to confirm that both has discussed
each item and they are both in agreement with their
plan regarding the medication use and appropriate
life-style changes. “The one-page Office-Gap checklist
was reported to be simple and easy to use by the
physicians in the study. The study met all the criteria
for the TIDieR checklist (Appendix 2).
Efficacy
Communication and decision confidence
Results of the COMRADE analysis show improvement
in patient satisfaction with provider communication and
confidence in decisions, based on principles of SDM
(Table 3). Relative to the baseline, satisfaction with com-
munication increased at the first GAP follow-up by 4.6
points (95 % CI: 2.6, 6.5, P < 0.001) and by 5.0 at the sec-
ond post-GAP follow-up (3.1, 7.0; p < 0.001). Similarly,
confidence in decision increased at the first follow-up by
3.7 points (1.3, 6.1; p < 0.05) and by 5.5 at the second
follow-up (3.0, 8.0; p < 0.001). These improvements were
in the small to medium effect size range.
Medication use
There were significant increases in the proportions of
patients using Aspirin/Plavix, statin and beta-blocker
during follow-up compared to baseline, with ORs for
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Aspirin 1.5 (95 % CI: 1.1, 2.2; p < 0.05) at 3-month, 1.9
(1.3, 2.9; p < 0.01) at 6-month, and 1.8 (1.2, 2.8; p < 0.01)
at 12-month; for Statin 1.1 (1.0, 1.3; p < 0.05) at 3-
months and 1.5 (1.1, 2.2; p < 0.05) at 12-month; and for
beta-blocker 1.8 (1.1, 2.9; p < 0.05) at 6-month and 12-
month (Table 4). The predicted probability for “global”
medication adherence over time revealed that compared
with baseline, the odds for adherence increased by 52 %
at 6-month (OR = 1.52, 95 % CI = 1.01, 2.29; p < 0.05)
and by 34 % at 12-month (OR = 1.34, CI = 0.87, 2.06
p = 0.189) (Table 4). Figure 2 depicts the predicted
probability and 95 % confidence intervals for global
medication adherence over time using the model in
the last column in Table 4.
Table 2 Demographics and baseline characteristics (N = 95)
Continuous variable Mean SD
Age (years) 53.2 10.3
Body mass index (BMI, kg/m2) 36.9 10.2
Charlson Index* 2.6 1.5
Total No. of Office-GAP visits completed 2.4 0.8




African American 35 36.8
Other race/ethnicity 11 11.6
Education
Less than high school 30 31.6
HS diploma or higher 65 68.4
Primary insurance









< 30 21 22.1
30–35 23 24.2
> 35 51 53.7
Office-GAP visit patterns
Patients completed only 1 visit 18 19.0
Only 2 visits 17 17.9




Dyslipidemia (hyperlipidemia) 65 76.5
Chronic pulmonary disease 19 22.4
Peripheral vascular disease 18 21.2
Myocardial infarction 13 15.3
Angina 10 11.8
Cerebrovascular disease 9 10.6
Congestive heart failure 8 9.4
Connective tissue disease 4 4.7
Peptic ulcer 8 9.4
Liver disease 2 2.4
Dementia 0 0
Table 3 Hierarchical linear models for COMRADE subscale
scores
Satisfaction β [95 % CI] Confidence β [95 % CI]
3 months 4.55*** 3.70**
[2.63, 6.46] [1.33, 6.07]
6 months 5.03*** 5.48***
[3.09, 6.97] [2.96, 8.00]
Age 0.10 0.06
[−0.04, 0.24] [−0.09, 0.22]
Black −1.07 −0.76
[−4.03, 1.88] [−4.02, 2.50]
Female −0.61 −0.84
[−3.37, 2.16] [−3.90, 2.21]
Medicaid −1.72 −1.92
[−5.54, 2.09] [−6.15, 2.32]
Medicare −0.13 −0.18
[−3.44, 3.18] [−3.82, 3.47]
Charlson index −1.36** −1.18*
[−2.34, −0.38] [−2.25, −0.10]
Intercept 39.72*** 39.32***
[36.74, 42.70] [35.97, 42.67]
N Obs. 205 205
Reference groups are: Pre-GAP; male; white or other race; other insurance or
uninsured. Age and Charlson index are centered at the means
COMRADE combined outcome measure for risk communication and treatment
decision making
*p < 0.05, **p < 0.01, ***p < 0.001
Table 2 Demographics and baseline characteristics (N = 95)
(Continued)
Diabetics with end organ damage 25 29.4
Renal failure 4 4.7
Any tumor 7 8.2
AIDS/Metastatic solid tumor/Leukemia/lymphoma 0 0
*% for Past medical history and Charlson index are based on 85 patients with
chart review
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Discussion
Our results demonstrate the feasibility of the Office-
GAP Program and these preliminary efficacy data sug-
gest it leads to improvement in patient satisfaction with
communication with their provider and medication use.
The medication use in the study was based on ACC/
AHA/ADA guidelines based care for secondary preven-
tion of heart disease for patients with diabetes and heart
disease. The Office-GAP tool was found to be almost
universally used in this study. The simplicity of the tools
and the team-based approach which involved patients
and providers/practice staff in training and implementa-
tion likely accounted for high use of Office-GAP tools.
The one-page Office-GAP checklist that enables physi-
cians’ to systematically consider evidence based care for
every patient during each encounter was reported to be
simple and easy to administer by the physicians. The
Office-GAP decision support tools provide educational
content and structure the clinical encounter.
Beyond establishing program feasibility, we are encour-
aged that the simultaneous training of physicians and pa-
tients in communication skills appeared to boost patients’
confidence in their decisions and their evaluation of pro-
viders’ communication as measured by COMRADE.
These are critical aspects of increased trust and strength-
ening of the provider-patient relationship. Importantly,
the improved COMRADE scores show improvement in
patients’ satisfaction with provider communication and
comfort with discussing prevention and treatment, and
making treatment decisions with their providers. This, in
itself, is an important improvement in the provider-
patient relationship. In addition, the Office-GAP pilot
Table 4 Odds ratio [95 % CI] for medication use over time
(1) (2) (3) (4) (5)
Aspirin/Plavix Statin ACEI/ABR Beta-blocker “Global” medication
adherence
3 months 1.50* 1.12* 1.21 1.31 1.19
[1.05, 2.15] [1.00, 1.25] [0.84, 1.75] [0.91, 1.89] [0.85, 1.66]
6 months 1.92** 1.34 1.38 1.75* 1.52*
[1.27, 2.92] [0.99, 1.81] [0.92, 2.09] [1.07, 2.85] [1.01, 2.29]
12 months 1.81** 1.52* 1.13 1.75* 1.34
[1.17, 2.79] [1.07, 2.16] [0.72, 1.78] [1.07, 2.85] [0.87, 2.06]
Age 1.02 0.99 1.03 0.99 1.03
[0.98, 1.06] [0.94, 1.04] [0.98, 1.08] [0.93, 1.06] [0.99, 1.08]
Black 0.90 1.16 0.90 0.43 0.87
[0.36, 2.22] [0.43, 3.08] [0.36, 2.28] [0.10, 1.84] [0.35, 2.13]
Female 1.27 2.06 0.77 0.77 0.72
[0.54, 2.97] [0.83, 5.07] [0.31, 1.89] [0.19, 3.10] [0.30, 1.70]
Medicaid 0.35 2.75 0.56 0.36 0.46
[0.11, 1.07] [0.80, 9.38] [0.17, 1.81] [0.07, 1.95] [0.15, 1.38]
Medicare 0.96 2.16 0.71 0.70 0.74
[0.34, 2.72] [0.73, 6.40] [0.24, 2.05] [0.11, 4.68] [0.26, 2.10]
Charlson index 1.16 1.03 0.83 1.09 0.83
[0.85, 1.59] [0.74, 1.42] [0.61, 1.13] [0.70, 1.71] [0.61,1.12]
N obs. 300 316 296 132 332
OR with 95 % confidence intervals in brackets
Reference groups are: Pre-GAP; male; white or other race; other insurance or uninsured, Age and Charlson index centered at their respective means (53.5 and 2.7)
*p < 0.05, **p < 0.01
Fig. 2 Global medication adherence
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study showed increase in medication use in this low-
income population. We suggest the improved relationship
may contribute to improved medication prescription use.
Previous studies have rarely shown an impact of commu-
nication skills interventions on patient behavior [17]. Our
results, however, are consistent with the findings of
Cooper et al. [48] who showed in their Hypertension
Patient-Physician Partnership Study that the greatest im-
provements in blood pressure control were seen among
patients who received coaching by community health
workers and among those whose physicians also received
patient-centered communication skill training.
A key component of the system is communication
skills training for both the patient and physician. A sec-
ond key is that the use of the Office-GAP checklist
brings the specific clinical decisions directly into the
patient encounter for systematic discussion and patient-
provider decision making. Results show improved phys-
ician prescribing behavior and patient follow-through.
Sustained improvement in medication and life style,
structured and supported by a team-based approach,
could lead to improved cardiovascular outcomes [49].
We studied minority and low-income populations who
are unlikely to be able to afford the cost of medications
without insurance coverage. Availability of insurance
coverage to almost everyone due to health care reform
should sustain access to these medications.
Our feasibility study sought to implement and evaluate
the proposed main intervention of a broader trial while
reducing threats to the validity of the future study [50].
Our results allow estimation of the probable effects of
our intervention. These results will likely enable estima-
tion of an adequately powered sample size for a planned
randomized controlled trial (RCT).
Several limitations are pertinent. Office-GAP imple-
mentation was tested in a FQHC in a small cohort
and not in a randomized control trial, limiting
generalizability. The educational intervention exposure for
physicians was limited to a one-time administration, and
may degrade over time; however, Office-GAP tools
assisted the follow-up interactions. Since we did not audio
or video record the encounters, there was no definitive
way to confirm how physicians and patients were actually
engaged in the SDM. However, at the end of the clinic
visit the physician and patient signed the checklist form to
confirm that both of them has reviewed and discussed all
the items. In addition, we are unable to disentangle the ef-
fects of the providers’ training and the patients’ training to
explain our results. The increase in medication use
may reflect more effective physician prescribing and
communication practices, as well as more effective
patient communication and activation. We did not
evaluate implementation cost in this pilot study. Finally,
since we did not track which patients formed a group at
each visit we could not take into account of the clustering
of patients in the analysis. Despite these study limitations,
this study has several strengths. We believe that the Of-
fice-GAP pilot initiative may provide the foundation
for future initiatives and that it is unique in several
ways. First the tools remind physicians, nurses and
patients of the key goals of therapy in real time and
in follow-up office visits. Office-GAP strengthened
shared decision making and resulted in improved pa-
tient satisfaction and confidence in decision made in
an underserved population not characterized by high
engagement at baseline. Second, the tools’ design was
very simple and easy to use at the point of care.
Third, all the physicians and practice staff were in-
volved in the training and implementation of the
tools and assisted in identifying the barriers to suc-
cessful implementation, a strategy previously proven
to be effective in influencing physician behavior [42].
Conclusion
The Office-GAP Program is feasible within the outpatient
clinical settings. It has the potential to improve shared
decision-making, satisfaction with provider communica-
tion, and evidence-based medication use for patients with
heart disease and/or diabetes. Improved satisfaction with
physician communication and confidence in decision may
be the key to improving medication use in underserved
populations. The Office-GAP Program could serve as a
model for implementation of guideline based care for
other chronic diseases in outpatient clinical settings.
Further evaluation is needed to establish feasibility
outside a clinical study, reach, effectiveness and cost-
effectiveness of this approach.
Appendix 1
Table 5 Medication eligibility criteria. Eligibility criteria for
prescribing medication to appropriate patient
Variable Eligibility criteria
Aspirin/Plavix Diagnosed with (1) coronary artery disease,
(2) peripheral vascular disease, or (3)
diabetes mellitus combined with one other
risk factor (for males’ age > 50, or for
females’ age > 60).
Beta-blockers Diagnosed with (1) angina, (2) congestive
heart failure paired with left ventricular
systolic dysfunction, (3) coronary artery
disease, (4) myocardial infarction, or (5)
peripheral vascular disease.
ACEI/ARB Diagnosed with either (1) congestive heart
failure paired with an ejection fraction < 40,
or (2) diabetes mellitus.
Statins & other
lipid-lowering agents
Diagnosed with (1) diabetes mellitus, (2)
coronary artery disease, (3) hyperlipidemia,
or (4) peripheral vascular disease.
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Appendix 2
Abbreviations
CHD, Coronary Heart Disease; F/U, Follow up; NP, Nurse Practitioner; Office-
GAP, Office-Guidelines Applied to Practice; PTC, Patient-Centered Method of
Communication; RA, Research Assistant; SDM, Shared Decision-Making.
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Table 6 TIDieR checklist. Template for intervention description and replication checklist
Item number Item Location
Primary paper Other details
1 Brief name: Provide the name of a phrase that describes
the intervention.
Page 1 Office-GAP intervention
2 Why: Describe any rationale, theory, or goal of the elements
essential to the intervention
Page 6 Introduction
3 Materials: Describe any physical or informational materials
used in the intervention, including those provided to
participants or used in intervention delivery or in training
of intervention providers. Provide information on where the
materials can be accessed (e.g., online appendix, URL).
Page 12, 13 Patient and provider intervention https://
www.acponline.org/practice-resources/
patient-education/resources
4 Procedures: Describe each of the procedures, activities,
and/or processes used in the intervention, including any
enabling or support activities.
Page 13, 14 Group visit and clinic visit
5 Who Provided: For each category of intervention provider
(e.g., psychologist, nursing assistant), describe their expertise,
background and any specific training given.
Page 10, 14 Family Physician, Internal medicine Physician,
Nurse Practitioner, Research Assistant
6 How: Describe the modes of delivery (e.g., face-to-face or
by some other mechanism, such as internet or telephone)
of the intervention and whether it was provided individually
or in a group.
Page 13, 14 Face-to-face group visit
7 Where: Describe the type(s) of location(s) where the
intervention occurred, including any necessary infrastructure
or relevant features.
Page 9 Group visit and clinic
8 When and How Much: Describe the number of times the
intervention was delivered and over what period of time
including the number of sessions, their schedule, and their
duration, intensity or dose.
Page 13 Patient intervention, group visits, and 2
follow up visits
9 Tailoring: If the intervention was planned to be personalized,
titrated or adapted, then describe what, why, when, and how.
N/A Intervention was not personalized,
titrated, or adapted
10 Modifications: If the intervention was modified during the
course of the study, describe the changes (what, why,
when, and how).
N/A
11 Planned: If intervention adherence or fidelity was assessed,
describe how and by whom, and if any strategies were used
to maintain or improve fidelity, describe them.
Page 14, 15 Intervention feasibility
12 Actual: If intervention adherence or fidelity was assessed, describe
the extent to which the intervention was delivered as planned.
Page 17, 18 Intervention feasibility and program fidelity
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